Literature DB >> 22327213

Human allograft rejection in humanized mice: a historical perspective.

Michael A Brehm1, Leonard D Shultz.   

Abstract

Basic research in transplantation immunology has relied primarily on rodent models. Experimentation with rodents has laid the foundation for our basic understanding of the biological events that precipitate rejection of non-self or allogeneic tissue transplants and supported the development of novel strategies to specifically suppress allogeneic immune responses. However, translation of these studies to the clinic has met with limited success, emphasizing the need for new models that focus on human immune responses to allogeneic tissues. Humanized mouse models are an exciting alternative that permits investigation of the rejection of human tissues mediated by human immune cells without putting patients at risk. However, the use of humanized mice is complicated by a diversity of protocols and approaches, including the large number of immunodeficient mouse strains available, the choice of tissue to transplant and the specific human immune cell populations that can be engrafted. Here, we present a historical perspective on the study of allograft rejection in humanized mice and discuss the use of these novel model systems in transplant biology.

Entities:  

Mesh:

Year:  2012        PMID: 22327213      PMCID: PMC4012846          DOI: 10.1038/cmi.2011.64

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  98 in total

1.  11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity.

Authors:  S C De Rosa; L A Herzenberg; L A Herzenberg; M Roederer
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

2.  Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question.

Authors:  E J Suchin; P B Langmuir; E Palmer; M H Sayegh; A D Wells; L A Turka
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

Review 3.  Chronic rejection.

Authors:  P Libby; J S Pober
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

4.  Transforming growth factor beta expression by human vascular cells inhibits interferon gamma production and arterial media injury by alloreactive memory T cells.

Authors:  A H Lebastchi; S F Khan; L Qin; W Li; J Zhou; N Hibino; T Yi; D A Rao; J S Pober; G Tellides
Journal:  Am J Transplant       Date:  2011-08-03       Impact factor: 8.086

5.  NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells.

Authors:  L D Shultz; P A Lang; S W Christianson; B Gott; B Lyons; S Umeda; E Leiter; R Hesselton; E J Wagar; J H Leif; O Kollet; T Lapidot; D L Greiner
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

Review 6.  Noncompliance in organ transplant recipients: a literature review.

Authors:  K Laederach-Hofmann; B Bunzel
Journal:  Gen Hosp Psychiatry       Date:  2000 Nov-Dec       Impact factor: 3.238

7.  Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice.

Authors:  K G Tournoy; S Depraetere; R A Pauwels; G G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

8.  Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.

Authors:  E J Wagar; M A Cromwell; L D Shultz; B A Woda; J L Sullivan; R M Hesselton; D L Greiner
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

9.  Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice.

Authors:  G Hoffmann-Fezer; C Gall; U Zengerle; B Kranz; S Thierfelder
Journal:  Blood       Date:  1993-06-15       Impact factor: 22.113

10.  Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.

Authors:  R Shiroki; N J Poindexter; E S Woodle; M S Hussain; T Mohanakumar; D W Scharp
Journal:  Transplantation       Date:  1994-06-15       Impact factor: 4.939

View more
  16 in total

1.  Selective, efficient modulation of activated CD4+ αβT cells by the novel humanized antibody GZ-αβTCR targeting human αβTCR.

Authors:  G Blank; C Welker; J Haarer; M Sterk; S Nadalin; V A C Yañez; T O Joos; A Menrad; D Snell; G LaCorcia; A Königsrainer; R Handgretinger; K Schilbach
Journal:  Bone Marrow Transplant       Date:  2014-11-17       Impact factor: 5.483

Review 2.  Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases.

Authors:  Iurii Koboziev; Yava Jones-Hall; John F Valentine; Cynthia Reinoso Webb; Kathryn L Furr; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2015-07       Impact factor: 5.325

Review 3.  Humanized Mouse Xenograft Models: Narrowing the Tumor-Microenvironment Gap.

Authors:  J Jason Morton; Gregory Bird; Yosef Refaeli; Antonio Jimeno
Journal:  Cancer Res       Date:  2016-09-01       Impact factor: 12.701

Review 4.  Humanized mouse models of genetic immune disorders and hematological malignancies.

Authors:  Rajeev K Tyagi; Jing Li; Justin Jacobse; Scott B Snapper; Dror S Shouval; Jeremy A Goettel
Journal:  Biochem Pharmacol       Date:  2019-10-18       Impact factor: 5.858

5.  Assessment of Angiogenesis and Cell Survivability of an Inkjet Bioprinted Biological Implant in an Animal Model.

Authors:  Beu P Oropeza; Carlos Serna; Michael E Furth; Luis H Solis; Cesar E Gonzalez; Valeria Altamirano; Daisy C Alvarado; Jesus A Castor; Jesus A Cedeno; Dante Chaparro Vega; Octavio Cordova; Isaac G Deaguero; Erwin I Delgado; Mario F Garcia Duarte; Mirsa Gonzalez Favela; Alba J Leyva Marquez; Emilio S Loera; Gisela Lopez; Fernanda Lugo; Tania G Miramontes; Erik Munoz; Paola A Rodriguez; Leila M Subia; Arahim A Zuniga Herrera; Thomas Boland
Journal:  Materials (Basel)       Date:  2022-06-24       Impact factor: 3.748

6.  Not All SCID Pigs Are Created Equally: Two Independent Mutations in the Artemis Gene Cause SCID in Pigs.

Authors:  Emily H Waide; Jack C M Dekkers; Jason W Ross; Raymond R R Rowland; Carol R Wyatt; Catherine L Ewen; Alyssa B Evans; Dinesh M Thekkoot; Nicholas J Boddicker; Nick V L Serão; N Matthew Ellinwood; Christopher K Tuggle
Journal:  J Immunol       Date:  2015-08-28       Impact factor: 5.422

Review 7.  Experimental models of cardiac transplantation: design determines relevance.

Authors:  William M Baldwin; Charles A Su; Thomas M Shroka; Robert L Fairchild
Journal:  Curr Opin Organ Transplant       Date:  2014-10       Impact factor: 2.640

Review 8.  Humanized Mouse Models of Clinical Disease.

Authors:  Nicole C Walsh; Laurie L Kenney; Sonal Jangalwe; Ken-Edwin Aryee; Dale L Greiner; Michael A Brehm; Leonard D Shultz
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

Review 9.  Humanized Mouse Models for Transplant Immunology.

Authors:  L L Kenney; L D Shultz; D L Greiner; M A Brehm
Journal:  Am J Transplant       Date:  2015-11-20       Impact factor: 8.086

10.  Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo.

Authors:  De-Kuan Chang; Raymond J Moniz; Zhongyao Xu; Jiusong Sun; Sabina Signoretti; Quan Zhu; Wayne A Marasco
Journal:  Mol Cancer       Date:  2015-06-11       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.